Faculty profile

Alain Moreau

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Alain Moreau

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
20 publications in the last five years, latest in 2026.
Senior (last) author on 14 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Education Health Minority Multidisciplinary Research Network Oral Health

Latest papers

Haptoglobin Phenotypes Stratify Post-Exertional Cognitive Dysfunction Associated with Altered Cerebral Oxygenation and Metabolic Signatures in Long COVID.
International journal of molecular sciences · 2026 · senior author
Raman Spectroscopy Combined with Machine Learning Reveals Myalgic Encephalomyelitis-Associated Biomolecular Signatures at Rest and After Standardized Stress.
International journal of molecular sciences · 2026
Irisin Signaling Resistance in Myalgic Encephalomyelitis: A Proposed Mechanistic Framework for Post-Exertional Malaise Involving the TSP-1-HSP90α-αvβ5 Axis.
International journal of molecular sciences · 2026 · senior author

All 46 publications

Latest funding

Network for Canadian Oral Health Research
CIHR · 2022 · Principal investigator
$2,000,000
The oral health of Canadians: an investigation of status and disease burden, access to care, risk determinants, and associations with systemic health and well-being
CIHR · 2020 · Co-investigator
$3,300,000

All 2 grants and awards

46 publications.

Haptoglobin Phenotypes Stratify Post-Exertional Cognitive Dysfunction Associated with Altered Cerebral Oxygenation and Metabolic Signatures in Long COVID.

Moezzi A, Elremaly W, Leveau C, Franco A, Nepotchatykh O, Armstrong CW, Moreau A

International journal of molecular sciences2026Senior author

DOI: 10.3390/ijms27157000 PMID: 42589652

Raman Spectroscopy Combined with Machine Learning Reveals Myalgic Encephalomyelitis-Associated Biomolecular Signatures at Rest and After Standardized Stress.

Heidarifard M, Moezzi A, Dallaire F, Ember K, Elremaly W, Caraus I, Franco A, Leblond F, Moreau A, Dehaes M

International journal of molecular sciences2026

DOI: 10.3390/ijms27114937 PMID: 42278463

Irisin Signaling Resistance in Myalgic Encephalomyelitis: A Proposed Mechanistic Framework for Post-Exertional Malaise Involving the TSP-1-HSP90α-αvβ5 Axis.

Souma B, Elremaly W, Akoume MY, Elbakry M, Godbout C, Moreau A

International journal of molecular sciences2026Senior author

DOI: 10.3390/ijms27114770 PMID: 42278300

PTPRN2 hypomethylation and PHB2-associated miR-153-3p maturation define dual epigenetic features linked to symptom variability in Myalgic encephalomyelitis.

Chalder L, Elremaly W, Li D, Fang Y, Caraus I, Leveau C, Elbakry M, Franco A, Godbout C, Di Tomasso G, Nepotchatykh E, Rostami-Afshari B, Gimenez M, Legault P, Moreau A

Journal of translational medicine2026Senior author

DOI: 10.1186/s12967-026-08162-6 PMID: 42010606

Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'".

Rostami-Afshari B, Elremaly W, Franco A, Moreau A

Journal of translational medicine2026Senior author

DOI: 10.1186/s12967-025-07583-z PMID: 41546078

A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID.

Fineberg D, Moreau A, Schneider-Futschik EK, Armstrong CW

ACS pharmacology & translational science2025

DOI: 10.1021/acsptsci.5c00229 PMID: 41189723

Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis.

Rostami-Afshari B, Elremaly W, McGregor NR, Huang KJK, Armstrong CW, Franco A, Godbout C, Elbakry M, Abdelli R, Moreau A

International journal of molecular sciences2025Senior author

DOI: 10.3390/ijms26188882 PMID: 41009450

Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic encephalomyelitis.

Moezzi A, Ushenkina A, Widgren A, Bergquist J, Li P, Xiao W, Rostami-Afshari B, Leveau C, Elremaly W, Caraus I, Franco A, Godbout C, Nepotchatykh O, Moreau A

Journal of translational medicine2025Senior author

DOI: 10.1186/s12967-025-07006-z PMID: 40877900

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A

Journal of translational medicine2025Senior author

DOI: 10.1186/s12967-025-06900-w PMID: 40813669

Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia.

Azimi G, Elremaly W, Elbakry M, Franco A, Godbout C, Moreau A

International journal of molecular sciences2025Senior author

DOI: 10.3390/ijms26167670 PMID: 40868993

Something wrong or missing on this profile? Suggest a correction

Alain Moreau

Research

Latest papers

Latest funding

Haptoglobin Phenotypes Stratify Post-Exertional Cognitive Dysfunction Associated with Altered Cerebral Oxygenation and Metabolic Signatures in Long COVID.

Raman Spectroscopy Combined with Machine Learning Reveals Myalgic Encephalomyelitis-Associated Biomolecular Signatures at Rest and After Standardized Stress.

Irisin Signaling Resistance in Myalgic Encephalomyelitis: A Proposed Mechanistic Framework for Post-Exertional Malaise Involving the TSP-1-HSP90α-αvβ5 Axis.

PTPRN2 hypomethylation and PHB2-associated miR-153-3p maturation define dual epigenetic features linked to symptom variability in Myalgic encephalomyelitis.

Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'".

A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID.

Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis.

Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic encephalomyelitis.

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia.

Network for Canadian Oral Health Research

The oral health of Canadians: an investigation of status and disease burden, access to care, risk determinants, and associations with systemic health and well-being

Frequent collaborators

Alain Moreau

Stefan Parent

Stefan Parent

Hubert Labelle

Florina Moldovan

Jean-Marc Mac-Thiong

Jean Ouellet

Emile Levy

Guillaume Bourque

Claire-Dominique Walker

Xiongbiao Chen

Frank Rauch

Anne-Marie Laberge

Jacek Majewski

Pascale Legault

Mathieu Dehaes

Edith Hamel

Marjolaine Roy-Beaudry

Kerry Lavender

Johanne Martel-Pelletier

Alain Moreau

Research

Latest papers

Latest funding

Haptoglobin Phenotypes Stratify Post-Exertional Cognitive Dysfunction Associated with Altered Cerebral Oxygenation and Metabolic Signatures in Long COVID.

Raman Spectroscopy Combined with Machine Learning Reveals Myalgic Encephalomyelitis-Associated Biomolecular Signatures at Rest and After Standardized Stress.

Irisin Signaling Resistance in Myalgic Encephalomyelitis: A Proposed Mechanistic Framework for Post-Exertional Malaise Involving the TSP-1-HSP90&#x3b1;-&#x3b1;v&#x3b2;5 Axis.

PTPRN2 hypomethylation and PHB2-associated miR-153-3p maturation define dual epigenetic features linked to symptom variability in Myalgic encephalomyelitis.

Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'".

A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID.

Circulating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis.

Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic encephalomyelitis.

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis.

Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia.

Network for Canadian Oral Health Research

The oral health of Canadians: an investigation of status and disease burden, access to care, risk determinants, and associations with systemic health and well-being

Frequent collaborators

Alain Moreau

Stefan Parent

Stefan Parent

Hubert Labelle

Florina Moldovan

Jean-Marc Mac-Thiong

Jean Ouellet

Emile Levy

Guillaume Bourque

Claire-Dominique Walker

Xiongbiao Chen

Frank Rauch

Anne-Marie Laberge

Jacek Majewski

Pascale Legault

Mathieu Dehaes

Edith Hamel

Marjolaine Roy-Beaudry

Kerry Lavender

Johanne Martel-Pelletier

Irisin Signaling Resistance in Myalgic Encephalomyelitis: A Proposed Mechanistic Framework for Post-Exertional Malaise Involving the TSP-1-HSP90α-αvβ5 Axis.